Rejoyn™: First FDA-Cleared Digital Therapeutic for MDD Symptoms Launches
Key Highlights Rejoyn™ cleared by FDA in March 2024 for treating major depressive disorder (MDD) symptoms. Available via prescription, Rejoyn™…
Browsing Tag
John Kraus
1 post